The Bioadaptor coronary implant (Elixir Medical) continues to outperform contemporary drug-eluting stent technology over ...

(UPDATED) Given the controversy surrounding short-term mortality as a quality metric for PCI in publicly reported databases, could the use of repeat target-lesion PCI be used instead to identify ...

The patient had erythema multiforme (EM), a polymorphous, often recurrent, inflammatory eruption characterized by abrupt onset of symmetrical macules, papules, bullae, and target lesions. The disease ...

Intravascular lithotripsy was noninferior to rotational atherectomy for preparing severely calcified coronary lesions for percutaneous coronary intervention (PCI), according to a head-to-head trial.

Epigenetic inactivation of HOXA5 and MSH2 gene in clear cell renal cell carcinoma. Background: Primary lesion in mRCC often shows necrotic change or only density changes to targeted therapy. As most ...

Please provide your email address to receive an email when new articles are posted on . PARIS — Biodegradable polymer sirolimus-eluting stents were superior to durable polymer everolimus-eluting ...

Please provide your email address to receive an email when new articles are posted on . A novel stent for treating long coronary lesions met its primary performance goal at 1 year. The 48-mm stent was ...

Around 1 in 5 patients with ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI) experienced target lesion failure (TLF) within 10 years, ...

Using 124I-PU-H71 PET imaging to predict intratumoral concentration in patients on a phase I trial of PU-H71. The predictive role of integrated BRCA1 and HERC2 mRNA expression in advanced non-small ...

The clinical presentation of EM can range from a mild, self-limited exanthematous form to a progressive, fulminating, life-threatening variant with extensive mucocutaneous epithelial necrosis. The ...